Comparing the Effectiveness of Two Dietary Interventions for Fecal Incontinence
1 other identifier
interventional
40
1 country
1
Brief Summary
Background: Fecal incontinence (FI) is a common complaint, and is often associated with diarrhea and urgency. Foods that are high in fermentable oligo-, di-, and mono-saccharides and polyols (FODMAPs) cause symptoms of diarrhea and urgency. Thus, assessing the impact of a low FODMAP diet in FI patients is needed. Aims:
- 1.Compare the treatment response with a low FODMAP vs. psyllium based on number of episodes in patients with FI.
- 2.Compare the efficacy of a low FODMAP diet vs. psyllium in patients with FI on pre-specified clinical and quality of life endpoints.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Oct 2014
Longer than P75 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 2, 2014
CompletedFirst Submitted
Initial submission to the registry
April 25, 2016
CompletedFirst Posted
Study publicly available on registry
July 11, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2019
CompletedAugust 28, 2019
August 1, 2019
4.7 years
April 25, 2016
August 27, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in number of FI episodes from baseline to week 4
Will compare baseline number of FI episodes to number of FI episodes at week 4
4 weeks from baseline
Secondary Outcomes (7)
number of people responding with decreased score in stool consistency
4 week span from baseline
number of people responding with reduction in stool frequency
4 weeks from baseline
Change in stool wet weight
4 weeks from baseline
Change in Fecal incontinence severity index (FISI)
4 weeks from baseline
Change in Fecal incontinence quality of life measure (FIqol)
4 weeks from baseline
- +2 more secondary outcomes
Study Arms (2)
low fodmap diet
ACTIVE COMPARATORSubjects receive formalized teaching in low fodmap diet by a dietician
psyllium
ACTIVE COMPARATORsubjects receive 7.1 g of psyllium daily
Interventions
Eligibility Criteria
You may qualify if:
- Experience at least 1 episode/week of unintentional loss of stool associated with diarrhea/loose stool (Bristol stool scale of 5 or greater).
- Subjects aged 18 and older meeting the Rome III criteria for Functional Fecal incontinence diagnostic criteria:
- Recurrent uncontrolled passage of fecal material in an individual and one or more of the following:
- Abnormal functioning of normally innervated and structurally intact muscles
- Minor abnormalities of sphincter structure and/or innervation
- Normal or disordered bowel habits, (i.e., diarrhea) Criteria fulfilled for the last 3 months
You may not qualify if:
- Abnormal innervation caused by lesion(s) within the brain (e.g., dementia), spinal cord, or sacral nerve roots, or mixed lesions (e.g., multiple sclerosis), or as part of a generalized peripheral or autonomic neuropathy
- Anal sphincter abnormalities associated with a multisystem disease (e.g., scleroderma)
- Structural or neurogenic abnormalities believed to be the major or primary cause of fecal incontinence
- Have cognitive dysfunction or unable to understand or provide written informed consent
- Pregnancy
- FI with solid stool only
- Comorbid medical problems that may affect gastrointestinal transit or motility: Inflammatory bowel disease, Extraintestinal disease known to affect the gastrointestinal system (i.e., scleroderma, unstable thyroid disease, etc.),Severe renal or hepatic disease
- Previous abdominal surgery other than appendectomy, cholecystectomy, and gynecologic/urologic surgery.
- Previous treatment with low FODMAP diet.
- Concurrent medications not permitted including probiotics, antibiotics, and narcotics.
- Active participation in another form of dietary therapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Michiganlead
- The Rome Foundationcollaborator
Study Sites (1)
University of Michigan
Ann Arbor, Michigan, 48109, United States
Related Publications (1)
Menees SB, Jackson K, Baker JR, Fenner DE, Eswaran S, Nojkov B, Saad R, Lee AA, Chey WD. A Randomized Pilot Study to Compare the Effectiveness of a Low FODMAP Diet vs Psyllium in Patients With Fecal Incontinence and Loose Stools. Clin Transl Gastroenterol. 2022 Feb 19;13(3):e00454. doi: 10.14309/ctg.0000000000000454.
PMID: 35060943DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stacy B Menees, MD
University of Michigan
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
April 25, 2016
First Posted
July 11, 2016
Study Start
October 2, 2014
Primary Completion
June 1, 2019
Study Completion
June 1, 2019
Last Updated
August 28, 2019
Record last verified: 2019-08